Intra-Cellular Therapies, Inc. Announces Upcoming Presentations On ITI-007 At The American Psychiatric Association 167th Annual Meeting, The Society Of Biological Psychiatry 69th Annual Meeting, And The International Review Of Psychosis & Bipolarity Annua

NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that several presentations related to ITI-007, the Company’s lead product candidate, will be featured at the following meetings:

Help employers find you! Check out all the jobs and post your resume.